Key result
Modulating the innate and adaptive immune responses post-myocardial infarction to resemble those of regenerative species may establish an environment that improves functional cardiac recovery.
Why the study?
Regeneration of the infarcted human heart remains an unmet ambition, with the hostile post-myocardial infarction immune response posing a significant obstacle to experimental regenerative therapies.
Understanding the distinct immune responses in regenerative animal models provides potential immunomodulatory targets to enhance cardiac repair and prevent heart failure post-myocardial infarction in humans.
Targeting post-MI sterile inflammation may aid regenerative therapies; animal data leave open human translation.
Despite decades of research, regeneration of the infarcted human heart remains an unmet ambition. A significant obstacle facing experimental regenerative therapies is the hostile immune response which arises following a myocardial infarction (MI). Upon cardiac damage, sterile inflammation commences via the release of pro-inflammatory meditators, leading to the migration of neutrophils, eosinophils and monocytes, as well as the activation of local vascular cells and fibroblasts. This response is amplified by components of the adaptive immune system. Moreover, the physical trauma of the infarction and immune-mediated tissue injury provides a supply of autoantigens, perpetuating a cycle of autoreactivity, which further contributes to adverse remodelling. A gradual shift towards an immune-resolving environment follows, culminating in the formation of a collagenous scar, which compromises cardiac function, ultimately driving the development of heart failure. Comparing the human heart with those of animal models that are capable of cardiac regeneration reveals key differences in the innate and adaptive immune responses to MI. By modulating key immune components to better resemble those of regenerative species, a cardiac environment may be established which would, either independently or via the synergistic application of emerging regenerative therapies, improve functional recovery post-MI.
No takes yet. Share an insight, caveat, or question.
Trajano et al. (2021) conducted a review in Myocardial infarction and heart failure. Immunomodulation was evaluated. Modulating the innate and adaptive immune responses post-myocardial infarction to resemble those of regenerative species may establish an environment that improves functional cardiac recovery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: